Biotech Clinuvel Pharmaceuticals now expanding UV research

MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to ... read more

Government not looking beyond CSL for vaccines

MELBOURNE: CSL’s Melbourne-made coronavirus vaccine is now available to Australians after the Therapeutic ... read more

Medical device research gets big funding jab

CANBERRA: Australia’s race to create world-leading medical devices suitable for human trials and ... read more

CSL’s vaccine achievement drives shares 1% higher

MELBOURNE: CSL shares have opened 1.5 0er cent higher this morning to $257.94 ... read more